Thomas Andrew Crockett - 30 Oct 2023 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
Issuer symbol
KALV
Transactions as of
30 Oct 2023
Net transactions value
$0
Form type
4
Filing time
01 Nov 2023, 16:12:52 UTC
Previous filing
21 Aug 2023
Next filing
21 Nov 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KALV Common Stock Gift $0 -8,000 -5.5% $0.000000 138,756 30 Oct 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.